Institutional Ownership Kymera Therapeutics, Inc. (KYMR)
This table provides information about the institutional ownership of Kymera Therapeutics, Inc. (KYMR). We have compiled data on the 180 institutions that hold shares in the stock, with a total of 67.4 Million shares, which have been reported (via 13F filing form) to have a value of $3.04 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Deer Management Co. LLC
Larchmont, NY |
May 15, 2025 Q1 2025 |
415,895
shares
|
$19 Million
5.33% of portfolio
|
Q1 2024
Reduced 32.47%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
395,468
shares
|
$18.1 Million
0.0% of portfolio
|
Q1 2025
Reduced 8.83%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
381,708
shares
|
$17.5 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.42%
|
|
|
Capital Research Global Investors
Los Angeles, CA |
May 12, 2025 Q1 2025 |
365,190
shares
|
$16.7 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
344,237
shares
|
$15.8 Million
0.0% of portfolio
|
Q1 2025
Reduced 20.67%
|
|
|
Gilder Gagnon Howe & CO LLC
New York, NY |
May 15, 2025 Q1 2025 |
318,381
shares
|
$14.6 Million
0.12% of portfolio
|
Q1 2025
Reduced 2.44%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
227,586
shares
|
$10.4 Million
0.01% of portfolio
|
Q1 2024
Added 38.64%
|
|
|
Td Asset Management Inc
|
May 07, 2025 Q1 2025 |
202,092
shares
|
$9.25 Million
0.01% of portfolio
|
Q1 2025
Reduced 11.58%
|
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
201,900
shares
|
$9.24 Million
0.01% of portfolio
|
Q1 2025
Added 2853.91%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2025 Q1 2025 |
183,300
shares
|
$8.39 Million
0.01% of portfolio
|
Q1 2025
Reduced 29.58%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
172,082
shares
|
$7.87 Million
0.0% of portfolio
|
Q1 2025
Reduced 28.23%
|
|
|
Schroder Investment Management Group
London, X0 |
May 13, 2025 Q1 2025 |
158,338
shares
|
$7.25 Million
0.0% of portfolio
|
Q1 2025
Reduced 3.39%
|
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
147,620
shares
|
$6.76 Million
0.01% of portfolio
|
Q1 2025
Reduced 15.04%
|
|
|
Foresite Capital Management Vi LLC
Larkspur, CA |
May 15, 2025 Q1 2025 |
146,332
shares
|
$6.7 Million
2.19% of portfolio
|
Q4 2024
New holding
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
May 15, 2025 Q1 2025 |
144,224
shares
|
$6.6 Million
0.02% of portfolio
|
Q1 2025
Reduced 2.05%
|
|
|
Nuveen, LLC
Charlotte, NC |
May 12, 2025 Q1 2025 |
143,238
shares
|
$6.55 Million
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
143,225
shares
|
$6.55 Million
0.0% of portfolio
|
Q4 2024
Added 2.17%
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
May 15, 2025 Q1 2025 |
142,587
shares
|
$6.52 Million
0.0% of portfolio
|
Q1 2025
Reduced 3.2%
|
|
|
Patient Square Capital LP
Menlo Park, CA |
May 14, 2025 Q1 2025 |
142,201
shares
|
$6.51 Million
1.61% of portfolio
|
Q1 2025
New holding
|
|
|
Aquilo Capital Management, LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
138,521
shares
|
$6.34 Million
7.39% of portfolio
|
Q1 2025
Reduced 24.52%
|
|
|
Checkpoint Capital L.P.
San Francisco, CA |
May 15, 2025 Q1 2025 |
136,605
shares
|
$6.25 Million
2.05% of portfolio
|
Q1 2025
Added 76.18%
|
|
|
Frontier Capital Management CO LLC
|
May 15, 2025 Q1 2025 |
131,963
shares
|
$6.04 Million
0.04% of portfolio
|
Q1 2025
Reduced 12.13%
|
|
|
Yiheng Capital Management, L.P.
San Francisco, CA |
May 16, 2025 Q1 2025 |
122,605
shares
|
$5.61 Million
0.33% of portfolio
|
Q1 2025
New holding
|
|
|
Axa S.A.
Paris, I0 |
May 15, 2025 Q1 2025 |
108,994
shares
|
$4.99 Million
0.01% of portfolio
|
Q1 2025
Reduced 0.13%
|
|
|
Affinity Asset Advisors, LLC
New York, NY |
May 14, 2025 Q1 2025 |
100,000
shares
|
$4.58 Million
0.31% of portfolio
|
Q1 2025
Added 150.0%
|